Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Diplomasi mendadak Prabowo jadi mediator AS - Iran: Langkah berani atau cari panggung?

(DPN)● Rencana Prabowo mediasi Amerika-Iran memicu keraguan.● Prabowo seakan ingin berperan seimbang untuk bertahan dari tekanan dari luar dan dalam negeri .● Tanpa daya tawar, media...

Masa depan padel: Antara gengsi atau turun kelas agar tren ini langgeng

● Padel sedang menjadi tren teratas aktivitas kaum urban sejak beberapa tahun terakhir.● Padel sudah menjelma sebagai validasi gaya hidup modern pemainnya.● Tren main padel akan sege...

The world’s largest climate finance deal was built to flounder: why funding fails to reach the front-line

Adopted in December 2015, the Paris Agreement commits countries to keeping global temperature rise below 2°C above pre-industrial levels. All 195 signatories set their own plans to meet this share...